Realty Income Corp
Change company Symbol lookup
Select an option...
O Realty Income Corp
DMO Western Asset Mortgage Opportunity Fund Inc
TEX Terex Corp
JEPI JPMorgan Equity Premium Income ETF
SPYD SPDR® Portfolio S&P 500 High Dividend ETF
AAPL Apple Inc
VYM Vanguard High Dividend Yield Index Fund ETF Shares
DGRO iShares Core Dividend Growth ETF
DIVO Amplify CWP Enhanced Dividend Income ETF
SCHD Schwab U.S. Dividend Equity ETF™
Go

Real Estate : Equity Real Estate Investment Trusts (REITs) | Large Cap Blend
Company profile

Realty Income Corporation is a real estate investment trust. The Company is engaged in acquiring and managing single-unit freestanding commercial properties under a long-term net lease agreement with its commercial clients. The Company owns and operates diversified portfolio of over 11,400 commercial properties. The Company’s properties are leased to over 1,100 different clients who operate in approximately 72 separate industries throughout all 50 states, as well as Puerto Rico, the United Kingdom and Spain. Its properties are leased to retail and industrial clients that have a service, non-discretionary and/or low-price-point component to their business. The Company’s property types include retail, industrial, and agriculture.

Closing Price
$67.86
Day's Change
-0.04 (-0.06%)
Bid
--
Ask
--
B/A Size
--
Day's High
68.85
Day's Low
67.50
Volume
(Average)
Volume:
3,235,288

10-day average volume:
3,175,945
3,235,288

Bernstein launches coverage of Canada's Tilray, Cronos and Canopy Growth but stops short of any buy ratings

12:16 pm ET November 2, 2022 (MarketWatch)
Print

By Steve Gelsi

Bernstein analyst sees the U.S. as the 'real prize' and issues no higher rating than market perform on the three stocks

Sanford C. Bernstein & Co. analyst Nadine Sarwat initiated coverage of three Canadian cannabis stocks on Wednesday but stopped short of any buy recommendations at current levels.

"Is the buzz gone? In the short term, yes, as Canada goes through growing pains and U.S. legalization efforts are patchy at best," Sarwat said. "However, in the long term, we see both meaningful and underappreciated growth in the U.S. (with or without legalization) and continued growth in Canadian cannabis spending."

Also read: Cannabis legalization goes up for a vote Nov. 8 in five states with a combined adult population of 13 million

Bernstein assigned market-perform ratings both to Tilray Brands Inc. (TLRY), with a $3.90 price target, and Cronos Group Inc. (CRON.T), with a $3 price target.

Canopy Growth Corp. (WEED.T) drew an underperform rating and a $1.50 price target just days after the stock rallied on plans by the company to group its U.S. businesses under a new entity called Canopy USA.

While Canopy USA will help realize revenue from its U.S. companies Wana Brands, Acreage and Jetty Extracts, no cash will flow from Canopy USA to Canopy Growth, because they will have separate management.

Sarwat said the Canopy USA transaction "is akin to shuffling cards in a deck (but the deck itself [is] not changing)" until the U.S. legalizes cannabis.

Canopy Growth also faces price compression in the Canadian market, market-share losses and headwinds from shifting its portfolio to premium cannabis flower.

She concluded that Canopy Growth stock is "meaningfully overvalued" at current levels.

Also read: Here's what the future of 'high' society looks like

Tilray earned more positive comments as "the highest quality company in our cannabis coverage," Sarwat said. She cited the company's diverse portfolio in other countries such as Germany, its distribution and its beverage-alcohol business, all of which have helped it withstand the volatility in the Canadian market.

Related: Leaked draft of German government's cannabis reform would ban imports -- for now

Cronos, which counts tobacco giant Altria Group Inc. (MO) as owner of 41% of its stock, remains different from other cannabis names because it's transitioning to an asset-light model with a cannabis-dominated business including adult-use pot in Canada, medical cannabis in Israel and hemp-based CBD products in the U.S.

"Its Canadian cannabis business has been growing strongly due to its increasing share of the fast growing edibles segment," Sarwat said. "We like this exposure, as we firmly believe that brand power in cannabis in the long-term lies in the beverages and edibles segments."

While growth in cannabis remains tantalizing for investors, Sarwat cautions that the sector isn't for the fainthearted after steep losses this year, although she stressed that the sector will expand over time.

She added that the U.S. multistate operators are "meaningfully undervalued" but did not mention any specific companies by name.

The AdvisorShares Pure U.S. Cannabis ETF (MSOS) has lost 59% of its value this year, compared with a 31% drop by the Nasdaq . The Cannabis ETF (THCX), which includes many Canadian cannabis stocks, is down nearly 64% year to date.

Overall, the total addressable cannabis market in Canada is expected to grow by about 14% a year until 2027, to about C$8.5 billion ($6.2 billion) from about C$4 billion in 2021.

Even without federal legalization, the regulated U.S. cannabis market is expected to grow to $56 billion by 2027, or potentially $90 billion with full federal legalization, up from $27 billion in 2021. At this size, it's comparable to the U.S. wine and spirits market and about half the size of the U.S. beer market.

"We firmly believe legalization is a matter of when, and not if. But while there are many green shoots, Washington remains in gridlock for now," Sarwat said.

Also read: Biden asks agencies to review marijuana's classification, pardons prior federal-possession offenses

Now read:Cannabis edibles company Wyld builds national footprint as it keeps hiring

-Steve Gelsi

	

(END) Dow Jones Newswires

November 02, 2022 12:16 ET (16:16 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.